Industry: Health care Region: France Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A French biotechnology company, founded in 2008, is headquartered in Reims. The company originated from the scientific research achievements of Reims University, and its core expertise lies in the research and development and application of synthetic bifunctional peptides, mainly focusing on the fields of skin wound repair, gum disease treatment and anti-aging skin care. Through the mode of combining independent research and development with technical authorization, the company has promoted a number of innovative projects into clinical research, and won the support of EU research funding, showing outstanding technical strength and development potential in the cross-field of tissue regeneration and medical beauty.
Introduction to core technologies:
The basis of innovation is the synthesis of bifunctional peptides, which are derived from extracellular matrix and can activate the body's own repair mechanism and promote cell renewal and tissue regeneration. Compared with traditional drugs, this method is closer to the natural repair process and has relatively low side effects, so it is suitable for medical and skin care scenarios.
Product application introduction:
1. Skin wound repair
It can accelerate the healing process and improve the wounds that are difficult to heal, such as severe burns and diabetic foot ulcers.
2. Oral and gingival health
Develop medical products containing innovative peptides to improve gingival inflammation and promote tissue regeneration.
3. Anti-aging skin care products
The application of active peptide in skin care formula can help reduce wrinkles and improve skin elasticity, and related products have shown positive effects in multi-center clinical trials.
Cooperation mode:
Seek partners who need tissue repair and regenerative peptide technical services in medical and beauty fields.